Human umbilical cord derivatives regenerate intervertebral disc

Area of Science:

• Regenerative Medicine
• Orthopedics
• Stem Cell Biology

Background:

• Intervertebral disc (IVD) degeneration, marked by nucleus pulposus (NP) loss, is a primary cause of lower back pain.
• Current treatments for degenerative disc disease are limited, driving interest in stem cell therapy.

Purpose of the Study:

• To evaluate the efficacy of human umbilical cord mesenchymal stem cells (MSCs) and their derived chondroprogenitor cells (CPCs) for regenerating damaged IVDs.
• To compare the regenerative capacity of MSCs and CPCs in a rabbit IVD degeneration model.

Main Methods:

• Transplantation of MSCs and CPCs into damaged rabbit IVDs.
• Assessment of cell survival, engraftment, and distribution within the NP.
• Histological, biochemical, and molecular analyses to evaluate IVD regeneration.

Main Results:

• Transplanted cells successfully survived, engrafted, and dispersed within the NP.
• CPCs significantly improved IVD histology, cellularity, extracellular matrix, water, and glycosaminoglycan content compared to MSCs.
• IVDs treated with CPCs showed increased expression of NP-specific markers (SOX9, aggrecan, collagen 2, FOXF1, KRT19).

Conclusions:

• In vitro differentiated CPCs from umbilical cord MSCs exhibit a greater capacity for IVD regeneration than MSCs alone.
• This study provides a strong foundation for clinical trials investigating stem cell-based treatments for degenerative disc disease.